Notice for maribavir (Takeda Pharmaceuticals Australia Pty Ltd)
Active ingredients
maribavir
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Film-coated tablet
Indication
For the treatment of cytomegalovirus infection and/or disease in patients with impaired cell-mediated immunity
Therapeutic area
Infectious diseases